We added lists, though, of drugs that were never contemplated for that, so I defer, I think, to many other experts out there who believe that Canada added a series of components that were hurdles, or more restrictive than what's permitted.
If I may, I would like to move to a comment--this has always been out there--that if we change the legislation of CAMR and it creates an environment where there will be less scientific research and development.... What evidence do you have to back up that statement? Have Rx&D said, for example, if CAMR is used 10 times over 10 years, they're going to invest less than Canada? Has there been any scientific research done to show that this bill is going to undermine Canadian pharmaceutical industries?